DNA adducts as link between in vitro and in vivo carcinogenicity – A case study with benzo[a]pyrene

To reduce the need for animal tests, in vitro assays are often used as alternative methods. To derive toxic doses for higher tier organisms from in vitro assay results, quantitative in vitro-in vivo extrapolation (qIVIVE) based on physiological-based toxicokinetic (PBTK) models is typically the pref...

Full description

Bibliographic Details
Main Authors: Martin Gerhards, Alexander Böhme, Kristin Schubert, Bernhard Kodritsch, Nadin Ulrich
Format: Article
Language:English
Published: Elsevier 2023-01-01
Series:Current Research in Toxicology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666027X22000342
_version_ 1827920107919114240
author Martin Gerhards
Alexander Böhme
Kristin Schubert
Bernhard Kodritsch
Nadin Ulrich
author_facet Martin Gerhards
Alexander Böhme
Kristin Schubert
Bernhard Kodritsch
Nadin Ulrich
author_sort Martin Gerhards
collection DOAJ
description To reduce the need for animal tests, in vitro assays are often used as alternative methods. To derive toxic doses for higher tier organisms from in vitro assay results, quantitative in vitro-in vivo extrapolation (qIVIVE) based on physiological-based toxicokinetic (PBTK) models is typically the preferred approach. Such PBTK models require many input parameters to address the route from dose to target site concentration. However, respective data is very often not available. Hence, our aim is to call attention to an alternative way to build a link between animal (in vivo) and cell-derived (in vitro) toxicity data. To this end, we selected the carcinogenic chemical benzo[a]pyrene (BaP) for our study. Our approach relates both in vitro assay and in vivo data to a main intermediate marker structure for carcinogenicity on the subcellular level – the BaP-DNA adduct BaP-7,8-dihydrodiol-9,10-epoxide-deoxyguanosine. Thus, BaP dose is directly linked to a measure of the toxicity-initiating event. We used Syrian hamster embryo (SHE) and Balb/c 3T3 cell transformation assay as in vitro data and compared these data to outcomes of in vivo carcinogenicity tests in rodents. In vitro and in vivo DNA adduct levels range within three orders of magnitude. Especially metabolic saturation at higher doses and interspecies variabilities are identified and critically discussed as possible sources of errors in our simplified approach. Finally, our study points out possible routes to overcome limitations of the envisaged approach in order to allow for a reliable qIVIVE in the future.
first_indexed 2024-03-13T04:07:52Z
format Article
id doaj.art-eb11fed079584845aa7529592609a7d5
institution Directory Open Access Journal
issn 2666-027X
language English
last_indexed 2024-03-13T04:07:52Z
publishDate 2023-01-01
publisher Elsevier
record_format Article
series Current Research in Toxicology
spelling doaj.art-eb11fed079584845aa7529592609a7d52023-06-21T06:59:57ZengElsevierCurrent Research in Toxicology2666-027X2023-01-014100097DNA adducts as link between in vitro and in vivo carcinogenicity – A case study with benzo[a]pyreneMartin Gerhards0Alexander Böhme1Kristin Schubert2Bernhard Kodritsch3Nadin Ulrich4Department of Ecological Chemistry, Helmholtz Centre for Environmental Research-UFZ, Permoserstr. 15, 04318 Leipzig, GermanyDepartment of Ecological Chemistry, Helmholtz Centre for Environmental Research-UFZ, Permoserstr. 15, 04318 Leipzig, GermanyDepartment of Molecular Systems Biology, Helmholtz Centre for Environmental Research-UFZ, Permoserstr. 15, 04318 Leipzig, GermanyDepartment of Bioanalytical Ecotoxicology, Helmholtz Centre for Environmental Research-UFZ, Permoserstr. 15, 04318 Leipzig, GermanyDepartment of Ecological Chemistry, Helmholtz Centre for Environmental Research-UFZ, Permoserstr. 15, 04318 Leipzig, Germany; Corresponding author.To reduce the need for animal tests, in vitro assays are often used as alternative methods. To derive toxic doses for higher tier organisms from in vitro assay results, quantitative in vitro-in vivo extrapolation (qIVIVE) based on physiological-based toxicokinetic (PBTK) models is typically the preferred approach. Such PBTK models require many input parameters to address the route from dose to target site concentration. However, respective data is very often not available. Hence, our aim is to call attention to an alternative way to build a link between animal (in vivo) and cell-derived (in vitro) toxicity data. To this end, we selected the carcinogenic chemical benzo[a]pyrene (BaP) for our study. Our approach relates both in vitro assay and in vivo data to a main intermediate marker structure for carcinogenicity on the subcellular level – the BaP-DNA adduct BaP-7,8-dihydrodiol-9,10-epoxide-deoxyguanosine. Thus, BaP dose is directly linked to a measure of the toxicity-initiating event. We used Syrian hamster embryo (SHE) and Balb/c 3T3 cell transformation assay as in vitro data and compared these data to outcomes of in vivo carcinogenicity tests in rodents. In vitro and in vivo DNA adduct levels range within three orders of magnitude. Especially metabolic saturation at higher doses and interspecies variabilities are identified and critically discussed as possible sources of errors in our simplified approach. Finally, our study points out possible routes to overcome limitations of the envisaged approach in order to allow for a reliable qIVIVE in the future.http://www.sciencedirect.com/science/article/pii/S2666027X22000342In vitro-in vivo extrapolation IVIVEBenzo[a]pyreneDNA adduct formation
spellingShingle Martin Gerhards
Alexander Böhme
Kristin Schubert
Bernhard Kodritsch
Nadin Ulrich
DNA adducts as link between in vitro and in vivo carcinogenicity – A case study with benzo[a]pyrene
Current Research in Toxicology
In vitro-in vivo extrapolation IVIVE
Benzo[a]pyrene
DNA adduct formation
title DNA adducts as link between in vitro and in vivo carcinogenicity – A case study with benzo[a]pyrene
title_full DNA adducts as link between in vitro and in vivo carcinogenicity – A case study with benzo[a]pyrene
title_fullStr DNA adducts as link between in vitro and in vivo carcinogenicity – A case study with benzo[a]pyrene
title_full_unstemmed DNA adducts as link between in vitro and in vivo carcinogenicity – A case study with benzo[a]pyrene
title_short DNA adducts as link between in vitro and in vivo carcinogenicity – A case study with benzo[a]pyrene
title_sort dna adducts as link between in vitro and in vivo carcinogenicity a case study with benzo a pyrene
topic In vitro-in vivo extrapolation IVIVE
Benzo[a]pyrene
DNA adduct formation
url http://www.sciencedirect.com/science/article/pii/S2666027X22000342
work_keys_str_mv AT martingerhards dnaadductsaslinkbetweeninvitroandinvivocarcinogenicityacasestudywithbenzoapyrene
AT alexanderbohme dnaadductsaslinkbetweeninvitroandinvivocarcinogenicityacasestudywithbenzoapyrene
AT kristinschubert dnaadductsaslinkbetweeninvitroandinvivocarcinogenicityacasestudywithbenzoapyrene
AT bernhardkodritsch dnaadductsaslinkbetweeninvitroandinvivocarcinogenicityacasestudywithbenzoapyrene
AT nadinulrich dnaadductsaslinkbetweeninvitroandinvivocarcinogenicityacasestudywithbenzoapyrene